CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH BMJ’s investigation findings raise questions about data integrity and regulatory oversight concerning Pfizer’s vaccine trial. A regional director told the BMJ that Pfizer falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in the pivotal phase III trial.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
